China Pharma Holdings (CPHI) Research & Development (2013 - 2026)
China Pharma Holdings (CPHI) recorded Research & Development of $19,135 in Q2 2026, down 8.7% from $20,952 a year earlier and down 77.2% from the prior quarter.
Powered by 
Analysis
China Pharma Holdings (CPHI) Research & Development (2013 - 2026) Analysis & Trends
On a TTM basis, China Pharma Holdings' Research & Development came in at $333,259 as of Jun 30, 2026, up 140.3% year-over-year; for FY2025, it came in at $280,901, down 1.1% from FY2024.
- Annual Research & Development has a five-year compound annual growth rate of -5.8% (FY2020 to FY2025).
- Across earlier years, Research & Development came in at $283,942 in FY2024 (+18.3%), $240,080 in FY2023 (+29.2%), $185,858 in FY2022 (-41.7%) and $318,964 in FY2021 (-15.6%).
- The Q2 2026 figure is the lowest quarterly Research & Development since Q4 2024.
- On a year-over-year basis, Research & Development rose in two of the last seven quarters, with growth averaging 2.7%.
- Peak year-over-year performance for Research & Development in the last five years was growth of 592.0% in Q2 2024, against a decline of 99.6% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at $83,762 (Q1 2026), $190,041 (Q4 2025) and $40,321 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 3.82 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 3.65 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 2.34 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | 9.74 Bn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 2.85 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 4.05 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 1.87 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | 1.76 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 2.81 Bn |
| 10 | China Pharma Holdings | 29.81 Mn | 28.69 Mn | 83,566.00 | 19,135.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 19,135.00 |
| Mar 31, 2026 | 83,762.00 |
| Dec 31, 2025 | 190,041.00 |
| Sep 30, 2025 | 40,321.00 |
| Jun 30, 2025 | 20,952.00 |
| Mar 31, 2025 | 29,587.00 |
| Dec 31, 2024 | 547.00 |
| Sep 30, 2024 | 87,610.00 |
| Jun 30, 2024 | 164,334.00 |
| Mar 31, 2024 | 31,451.00 |
| Dec 31, 2023 | 147,552.00 |
| Sep 30, 2023 | 45,773.00 |
| Jun 30, 2023 | 23,747.00 |
| Mar 31, 2023 | 23,008.00 |
| Dec 31, 2022 | 27,999.00 |
| Sep 30, 2022 | 88,747.00 |
| Jun 30, 2022 | 15,063.00 |
| Mar 31, 2022 | 54,049.00 |
| Dec 31, 2021 | 54,048.00 |
| Sep 30, 2021 | 21,374.00 |
API Access
China Pharma Holdings Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CPHI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CPHI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CPHI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();